NuVue Therapeutics, Inc.

Home

Company

Milestones

Technologies

Enhanced Ultrasound

Microencapsulation

Cryothermal Effects

Diagnostic Products

ColorMark-A Biopsy Needle

ColorMark-C Biopsy Needle

BrightMark Tissue Markers

Therapeutic Products

ChemoAblator

CryoChemoAblator

NuVue Chemo

Management

Roger Kolasinski

James Stuber

James Kulinski

Patrick Le Pivert

Dennis Morrison

Mark Ehlert

News

510(k) Approval Received

Best Life Sciences Co

Contact

Legal

Cryothermal Effects

The third platform technology developed by NuVue Therapeutics consists of patented and proprietary methods of using cryothermal effects– the cooling of tissues for therapeutic purposes.

 

With several issued and pending patents, this technology has been developed at NuVue under the leadership of Dr. Patrick Le Pivert. 

 

NuVue’s cryothermal technology leverages the Company’s other technologies, when used in combination, into a powerful, integrated technology platform. 


NuVue Therapeutics, Inc.  Copyright 2011.  All rights reserved.

Website powered by Network Solutions®